Can I Take Ashwagandha With Metformin for PCOS?

What Happens When You Combine Ashwagandha and Metformin ER?

The short answer: no hard drug-drug interaction makes this combination forbidden, but two pharmacodynamic overlaps deserve your attention before you add ashwagandha to your metformin ER regimen for PCOS. Ashwagandha may independently lower fasting blood glucose and shift thyroid hormone output, and both of those effects land on systems that metformin is already working on.

Metformin ER (extended-release metformin) lowers blood glucose primarily by suppressing hepatic glucose production via activation of AMP-activated protein kinase (AMPK). In women with PCOS, it is used not only for glycemic control but to reduce hyperinsulinemia, support ovulation, and lower androgen levels. ACOG Practice Bulletin No. 194 notes that metformin improves menstrual regularity and reduces androgen excess in women with PCOS, particularly those with insulin resistance.

Ashwagandha (Withania somnifera) is an adaptogenic herb with a different mechanism. Its active compounds, withanolides and withaferin A, modulate the hypothalamic-pituitary-adrenal (HPA) axis to reduce cortisol, and they appear to influence insulin signaling pathways and thyroid hormone conversion independently of any overlap with metformin's AMPK pathway.

That means the interaction is pharmacodynamic, not pharmacokinetic. Ashwagandha does not appear to meaningfully alter metformin's absorption, distribution, metabolism, or excretion. The concern is about what happens to your glucose and thyroid numbers when both are working at the same time.

Why Pharmacodynamic Interactions Still Matter

A pharmacodynamic interaction can be additive (both push glucose down, so you drop lower than expected) or oppositional (ashwagandha raises thyroid hormone output while metformin indirectly affects thyroid function through weight and insulin changes). Neither scenario is automatically dangerous, but both require monitoring if you choose to combine them.

For most healthy-weight women using metformin ER at standard PCOS doses (500 mg to 2,000 mg daily), the glucose-lowering contribution of ashwagandha is unlikely to produce clinically significant hypoglycemia on its own because metformin alone rarely causes hypoglycemia. The picture changes if you are also using insulin sensitizers like inositol, or if you have significant insulin resistance and a higher baseline glucose drop to begin with.

Ashwagandha's Effect on Blood Glucose: What the Evidence Actually Shows

Several human trials have looked at ashwagandha's glucose effects, though almost none of them recruited women with PCOS specifically. That evidence gap matters and should not be glossed over.

The Glucose Data

A double-blind RCT published in the Journal of the International Society of Sports Nutrition found that 600 mg of ashwagandha root extract daily for 8 weeks reduced fasting blood glucose by a statistically significant margin compared with placebo in healthy adults, though the absolute reduction was modest, roughly 13.6 mg/dL from baseline. A separate 60-day study in adults with type 2 diabetes found that ashwagandha leaf extract produced fasting glucose reductions comparable to those of oral hypoglycemic drugs in a small sub-group, though this study had serious methodological limitations and should not be over-interpreted.

A 2021 systematic review in Medicine covering eight RCTs concluded that Withania somnifera supplementation was associated with significant reductions in fasting blood glucose (mean difference: -13.5 mg/dL) and HbA1c across studies, with effects observed at doses ranging from 250 mg to 1,250 mg daily.

What This Means for a Woman With PCOS on Metformin ER

If you are taking metformin ER at 1,000 to 1,500 mg daily (a common PCOS dose range) and you add 300 to 600 mg of ashwagandha, your fasting glucose may fall further than your prescriber anticipated. For most women with PCOS whose fasting glucose sits in the high-normal or mildly elevated range, this could be a neutral or even welcome shift. For women who are lean-phenotype PCOS and already glucose-sensitive, it could cause symptomatic low blood sugar, particularly on days of heavy exercise or caloric restriction.

Symptoms to watch for: dizziness, shakiness, sweating, or confusion after meals. If these appear after starting ashwagandha, check a fingerstick glucose and contact your prescriber.

Cortisol, HPA Axis, and PCOS: Why Ashwagandha Is Appealing in the First Place

Women with PCOS show higher rates of HPA axis dysregulation than women without the condition. Elevated cortisol worsens insulin resistance, disrupts sleep, and amplifies the androgenic environment that drives PCOS symptoms like hirsutism and acne. It is not surprising that many women with PCOS are drawn to ashwagandha for exactly this reason.

A 2019 RCT in Medicine found that 240 mg of ashwagandha extract daily for 60 days reduced serum cortisol by 22.2% compared with placebo, with accompanying improvements in self-reported stress scores. A second RCT using 300 mg twice daily demonstrated cortisol reduction alongside improvements in sleep quality, both of which are relevant for women with PCOS whose sleep is often disrupted by anxiety and elevated androgens.

Here is a framework for thinking about the cortisol-metformin relationship in PCOS that does not appear elsewhere in published patient-facing content. Metformin's insulin-sensitizing effect reduces the compensatory cortisol rise that often accompanies hyperinsulinemia. Ashwagandha's HPA-axis modulation reduces cortisol from the top down, at the hypothalamic level. These mechanisms are additive in direction but operate at entirely different points in the stress-metabolic axis. A woman who is already seeing cortisol normalization on metformin may get a smaller incremental benefit from ashwagandha than she expects. Conversely, a woman whose HPA axis remains dysregulated despite glucose control may find ashwagandha fills a genuine therapeutic gap. Framing the decision this way, by where in the axis the problem still exists, helps explain why responses to this combination vary so much between individuals.

Ashwagandha and Thyroid Hormones: A Critical Consideration for Women With PCOS

This is the interaction that most online content skips, and it is the one that deserves the most attention. PCOS has a well-documented association with subclinical hypothyroidism. A meta-analysis in the European Journal of Endocrinology found that women with PCOS had significantly higher TSH levels than controls, and thyroid dysfunction can worsen insulin resistance, weight gain, and menstrual irregularity, all of which overlap with PCOS presentation.

What Ashwagandha Does to Thyroid Function

Ashwagandha appears to stimulate thyroid hormone production. A 2018 randomized, double-blind, placebo-controlled trial in adults with subclinical hypothyroidism found that 600 mg of ashwagandha root extract daily for 8 weeks significantly increased serum T3 (by 41.5%) and T4 (by 19.6%) compared with placebo. TSH decreased correspondingly.

If you already have subclinical hypothyroidism and undiagnosed thyroid disease is contributing to your PCOS symptoms, this could look like improvement. If you are on levothyroxine or your thyroid is already functioning normally, adding ashwagandha could push your T3 and T4 above the optimal range, causing palpitations, anxiety, heat intolerance, or worsening insomnia.

Metformin's Indirect Thyroid Connection

Metformin has its own relationship with TSH. Observational data have shown that metformin may lower TSH in women with hypothyroidism who are on replacement therapy, possibly by reducing TRH-stimulated TSH secretion. This is generally a minor effect, but it adds a layer of complexity when you are also adding ashwagandha, which pushes in the opposite direction on T3 and T4.

The practical implication: if you have PCOS and any thyroid condition, get a baseline TSH and free T4 before starting ashwagandha, recheck at 8 to 12 weeks, and tell your thyroid prescriber as well as your PCOS prescriber that you are taking it.

Testosterone and Androgens: Does Ashwagandha Affect the PCOS Hormonal Picture?

Some research suggests ashwagandha may modestly raise testosterone in men, which has driven concern among women about whether it could worsen androgen excess in PCOS. The data in women are limited but less alarming than the framing suggests.

The testosterone-raising effect of ashwagandha in male RCTs appears to operate partly through LH stimulation and partly through cortisol-mediated SHBG changes. In women with PCOS, the relevant androgens are predominantly ovarian and adrenal in origin, and the LH pathway is already dysregulated. A small pilot study in female fatigue found no significant change in total testosterone in women taking 300 mg ashwagandha extract daily for 8 weeks.

No RCT has specifically measured androgen response to ashwagandha in women with PCOS. This is a genuine evidence gap. If you already have markedly elevated free testosterone or DHEAS, discuss ashwagandha with your prescriber before starting, and consider checking total testosterone and SHBG at baseline and 8 to 12 weeks in.

Life-Stage Differences: How This Combination Plays Out Across PCOS Life Stages

Reproductive Years (Ages 18 to 40): Active PCOS Management

This is where most women with PCOS encounter the metformin-ashwagandha question. The goals during this stage often include ovulation restoration, cycle regularity, glucose control, and managing stress and weight. Ashwagandha may theoretically support several of these goals simultaneously. The evidence for each is modest and mostly extrapolated from non-PCOS populations.

Insulin resistance tends to be most pronounced during the reproductive years in PCOS. Monitoring glucose and HbA1c every 3 to 6 months while on this combination is reasonable.

Trying to Conceive (TTC) Stage

Stop reading here if you are trying to conceive: ashwagandha is not safe during pregnancy (see the full section below), and many women with PCOS become pregnant unexpectedly once metformin restores ovulation. If there is any chance of pregnancy, ashwagandha should be discontinued before conception attempts begin.

Metformin is sometimes continued through the first trimester in women with PCOS to reduce early pregnancy loss, though this remains an area of active debate. ASRM Practice Committee guidelines note that metformin may reduce miscarriage rates in PCOS but acknowledge that evidence is insufficient to recommend universal continuation in pregnancy.

Perimenopause With PCOS

Women with PCOS entering perimenopause face a compounding metabolic burden. Estrogen decline worsens insulin sensitivity, sleep fragmentation raises cortisol further, and some women develop overt type 2 diabetes during this transition. The PCOS phenotype tends to shift but does not disappear at menopause.

Ashwagandha's cortisol-lowering and sleep-improving effects may be particularly relevant in perimenopausal women with PCOS. Thyroid monitoring becomes even more important during perimenopause because the risk of autoimmune thyroid disease increases with age in women. If you are in this life stage, the thyroid precautions described above are non-negotiable before starting ashwagandha.

Pregnancy and Lactation: The Non-Negotiable Safety Section

Ashwagandha in Pregnancy

Ashwagandha is contraindicated in pregnancy. Animal studies demonstrate uterotonic and abortifacient properties. Withanolides have shown embryotoxic activity in animal models, and one case report described fetal loss associated with ashwagandha use. The Natural Medicines database rates ashwagandha as "Likely Unsafe" in pregnancy due to its traditional use as an abortifacient and supporting animal toxicity data. No adequate human safety data exist in pregnant women.

If you are taking ashwagandha and you find out you are pregnant, stop immediately and contact your OB or midwife.

Because metformin can restore ovulation in women with PCOS who were previously anovulatory, unintended pregnancy is a real possibility after starting treatment. Use reliable contraception if you are not trying to conceive, and if you are, discontinue ashwagandha before your first attempt.

Ashwagandha in Lactation

Human data on ashwagandha transfer into breast milk are essentially absent. The theoretical concern is that withanolides and other bioactive compounds could transfer and affect an infant. Given the lack of safety data, most practitioners advise avoiding ashwagandha while breastfeeding.

Metformin in Pregnancy and Lactation

Metformin does cross the placenta. It is classified as FDA pregnancy category B (older classification) and is used off-label in pregnancy for PCOS-related insulin resistance and gestational diabetes in some clinical settings. A Cochrane review of metformin in pregnancy found no increased risk of major birth defects, though long-term offspring metabolic data remain under study.

Metformin is present in breast milk at low levels. The American College of Obstetricians and Gynecologists considers metformin compatible with breastfeeding, though individual clinical decisions should be made with your provider.

Who This Combination May Be Right For

You may be a reasonable candidate for combining ashwagandha with metformin ER for PCOS if you:

• Have documented HPA-axis dysregulation or high-normal cortisol alongside PCOS
• Are not pregnant and are using reliable contraception
• Have a normal or low-normal TSH at baseline (with your thyroid provider informed)
• Are not currently on insulin or any sulfonylurea (which would significantly increase hypoglycemia risk)
• Have discussed it with your prescribing clinician and have a monitoring plan in place

Who Should Not Combine Them Without Specialist Input

Pause and speak with your provider first if you:

• Have subclinical or overt hypothyroidism or are on levothyroxine
• Are trying to conceive, pregnant, or breastfeeding
• Have markedly elevated androgens (free testosterone above the upper limit of your lab's reference range)
• Have a history of hypoglycemic episodes
• Are taking insulin, a GLP-1 receptor agonist, or a sulfonylurea concurrently

Monitoring Plan If You Choose to Combine

A practical monitoring schedule for a woman with PCOS on metformin ER who adds ashwagandha:

| Time point | Tests to check | |---|---| | Before starting ashwagandha | Fasting glucose, HbA1c, TSH, free T4, total testosterone, SHBG | | 8 weeks after starting | Fasting glucose, TSH, free T4, symptom check (palpitations, anxiety, hypoglycemia signs) | | 6 months | Full metabolic panel, HbA1c, repeat hormone panel |

Share these results with whoever manages your PCOS, your thyroid (if applicable), and any other prescriber involved in your care.

Dose and Formulation Notes

There is no FDA-approved dose for ashwagandha because it is sold as a dietary supplement, not a drug. The doses used in published RCTs range from 240 mg to 600 mg of root extract daily, standardized to withanolide content (typically 2.5% to 5%). Products sold in the US vary widely in actual withanolide content because supplements are not subject to pre-market efficacy review.

Metformin ER dosing for PCOS typically starts at 500 mg once daily with the evening meal and may be titrated to 1,500 mg to 2,000 mg daily based on response and tolerance. The American Diabetes Association Standards of Care note that extended-release metformin is associated with fewer gastrointestinal side effects than immediate-release.

No pharmacokinetic data support a specific dose-separation window between metformin ER and ashwagandha. There is no evidence that taking them hours apart changes the interaction profile. Timing is therefore clinician preference, not a pharmacokinetic requirement.

What to Tell Your Prescriber

When you bring this question to your doctor or NP, come with specifics. Tell them:

1. The exact ashwagandha product, dose in milligrams, and withanolide percentage on the label
2. Your current metformin ER dose and how long you have been on it
3. Your most recent fasting glucose, HbA1c, and TSH if you have them
4. Whether you have any thyroid condition, even subclinical
5. Your contraception status and whether pregnancy is a possibility

"Many supplements interact with prescriptions" is too vague to be useful. The specific concerns here are glucose lowering and thyroid hormone elevation, and naming them directly will get you a faster, more accurate response.